2006
DOI: 10.1016/j.bbrc.2006.03.176
|View full text |Cite
|
Sign up to set email alerts
|

Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
148
1
5

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 208 publications
(168 citation statements)
references
References 28 publications
7
148
1
5
Order By: Relevance
“…Modifications in the gut microbiota profile promoted by antibiotic therapy induced an increase in the portal levels of circulating acetate. Acetate has the capacity to activate AMPK in liver and muscle [31], increasing fatty acid oxidation [32]. In a corroborative way, we showed that after oral administration and venous infusion of acetate in mice, phosphorylation of AMPK and ACC was increased.…”
Section: Discussionsupporting
confidence: 64%
“…Modifications in the gut microbiota profile promoted by antibiotic therapy induced an increase in the portal levels of circulating acetate. Acetate has the capacity to activate AMPK in liver and muscle [31], increasing fatty acid oxidation [32]. In a corroborative way, we showed that after oral administration and venous infusion of acetate in mice, phosphorylation of AMPK and ACC was increased.…”
Section: Discussionsupporting
confidence: 64%
“…Acetic acid reduced the expression of genes involved in gluconeogenesis and lipogenesis, which is partially regulated by AMPK. They also reported that sodium acetate, in the form of neutralized AcOH, directly activated AMPK and lowered the expression of genes such as for glucose-6-phosphatase (Sakakibara et al 2006). These results indicate that the Table 3.…”
Section: Discussionmentioning
confidence: 98%
“…Sakakibara et al (2006) revealed the efficacy of acetic acid on reducing fasting plasma glucose level and hemoglobin A1c by giving mice 0.3% acetic acid for 8 weeks. Acetic acid reduced the expression of genes involved in gluconeogenesis and lipogenesis, which is partially regulated by AMPK.…”
Section: Discussionmentioning
confidence: 99%
“…PGC-1α in turn regulates several transcriptional factors such as peroxisome proliferator-activated receptor (PPAR)-α, PPAR-γ, PPAR-δ, and farnesoid X receptor (FXR), all of which regulate glucose-, lipid-, and cholesterol metabolism [42][43][44][45][46]. Furthermore, AMPK activation reduces hepatic expression of genes involved in gluconeogenesis, like glucose-6-phosphatase [46]. Interestingly, both PPARα and PPARγ have been used as pharmaceutical substrates for lipid-lowering (fibrates) and insulinsensitizing (thiazolidinediones) drugs.…”
Section: Glucose Metabolismmentioning
confidence: 99%